Analysis of lung cancer risk model (PLCO(M2012) and LLP(v2)) performance in a community-based lung cancer screening programme
AuthorsLebrett, M. B.
Barber, P. V.
Robbins, H. A.
Crosbie, P. A. J.
AffiliationDivision of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester
MetadataShow full item record
AbstractIntroduction: Low-dose CT (LDCT) screening of high-risk smokers reduces lung cancer (LC) specific mortality. Determining screening eligibility using individualised risk may improve screening effectiveness and reduce harm. Here, we compare the performance of two risk prediction models (PLCOM2012 and Liverpool Lung Project model (LLPv2)) and National Lung Screening Trial (NLST) eligibility criteria in a community-based screening programme. Methods: Ever-smokers aged 55-74, from deprived areas of Manchester, were invited to a Lung Health Check (LHC). Individuals at higher risk (PLCOM2012 score ?1.51%) were offered annual LDCT screening over two rounds. LLPv2 score was calculated but not used for screening selection; ?2.5% and ?5% thresholds were used for analysis. Results: PLCOM2012 ?1.51% selected 56% (n=1429) of LHC attendees for screening. LLPv2 ?2.5% also selected 56% (n=1430) whereas NLST (47%, n=1188) and LLPv2 ?5% (33%, n=826) selected fewer. Over two screening rounds 62 individuals were diagnosed with LC; representing 87% (n=62/71) of 6-year incidence predicted by mean PLCOM2012 score (5.0%). 26% (n=16/62) of individuals with LC were not eligible for screening using LLPv2 ?5%, 18% (n=11/62) with NLST criteria and 7% (n=5/62) with LLPv2 ?2.5%. NLST eligible Manchester attendees had 2.5 times the LC detection rate than NLST participants after two annual screens (?4.3% (n=51/1188) vs 1.7% (n=438/26 309); p<0.0001). Adverse measures of health, including airflow obstruction, respiratory symptoms and cardiovascular disease, were positively correlated with LC risk. Coronary artery calcification was predictive of LC (adjOR 2.50, 95% CI 1.11 to 5.64; p=0.028). Conclusion: Prospective comparisons of risk prediction tools are required to optimise screening selection in different settings. The PLCOM2012 model may underestimate risk in deprived UK populations; further research focused on model calibration is required. Keywords: lung cancer.
CitationLebrett MB, Balata H, Evison M, Colligan D, Duerden R, Elton P, et al. Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme. Thorax. 2020;75(8):661-8.
- Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
- Authors: Balata H, Harvey J, Barber PV, Colligan D, Duerden R, Elton P, Evison M, Greaves M, Howells J, Irion K, Karunaratne D, Mellor S, Newton T, Sawyer R, Sharman A, Smith E, Taylor B, Taylor S, Tonge J, Walsham A, Whittaker J, Vestbo J, Booton R, Crosbie PA
- Issue date: 2020 Aug
- Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
- Authors: Tammemägi MC, Ten Haaf K, Toumazis I, Kong CY, Han SS, Jeon J, Commins J, Riley T, Meza R
- Issue date: 2019 Mar 1
- A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor.
- Authors: Wilson DO, Weissfeld J
- Issue date: 2015 Jul
- Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
- Authors: Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R
- Issue date: 2017 Apr
- Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
- Authors: Katki HA, Kovalchik SA, Petito LC, Cheung LC, Jacobs E, Jemal A, Berg CD, Chaturvedi AK
- Issue date: 2018 Jul 3